Engineers Gate Manager LP

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1620220 NEW YORK, NY

Position in MDGL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$708,774

-$4,362,242 QoQ

Shares Held

1,320

-84.8% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#223

of 411 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $195,993,154 across 162 Biotechnology names. MDGL ranks #68 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$708,774	1,320	-84.8%	Shares	Sole	2026-08-14
2025-12-31	$5,071,016	8,708	+196.8%	Shares	Sole	2026-02-17
2025-09-30	$1,345,708	2,934	-33.7%	Shares	Sole	2025-11-14
2025-06-30	$1,338,576	4,423	+194.7%	Shares	Sole	2025-08-14
2024-09-30	$318,542	1,501	-15.5%	Shares	Sole	2024-11-14
2023-09-30	$259,367	1,776	-27.7%	Shares	Sole	2023-11-14
2023-06-30	$567,105	2,455	-55.0%	Shares	Sole	2023-08-14
2023-03-31	$1,321,770	5,456	-9.1%	Shares	Sole	2023-05-15
2021-06-30	$584,654	6,002	+30.4%	Shares	Sole	2021-08-16
2020-03-31	$307,229	4,602	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.